F
Fazlul H. Sarkar
Researcher at Wayne State University
Publications - 626
Citations - 48133
Fazlul H. Sarkar is an academic researcher from Wayne State University. The author has contributed to research in topics: Cancer & Pancreatic cancer. The author has an hindex of 114, co-authored 625 publications receiving 44744 citations.
Papers
More filters
Journal ArticleDOI
Molecular alterations associated with improved survival in pancreatic cancer patients treated with radiation or chemotherapy.
TL;DR: Findings suggest promising opportunities for gene therapies designed to enhance p21 expression or restore wild-type K-ras or p53 function in Pancreas cancer patients whose tumors express p21 show significant survival advantages when treated with chemotherapy or radiation therapy.
Journal ArticleDOI
B-DIM impairs radiation-induced survival pathways independently of androgen receptor expression and augments radiation efficacy in prostate cancer
Vinita Singh-Gupta,Sanjeev Banerjee,Christopher K. Yunker,Joseph T. Rakowski,Michael C. Joiner,Andre Konski,Fazlul H. Sarkar,Gilda G. Hillman +7 more
TL;DR: It is demonstrated that B-DIM augments radiation-induced cell killing and tumor growth inhibition and impairs critical survival signaling pathways activated by radiation, leading to enhanced cell killing.
Journal ArticleDOI
Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells.
Prasad Dandawate,Aamir Ahmad,Jyoti Deshpande,K. Venkateswara Swamy,Ejazuddin M. Khan,Madhukar Khetmalas,Subhash Padhye,Subhash Padhye,Fazlul H. Sarkar +8 more
TL;DR: Cytotoxicity of novel plumbagin hydrazones against estrogen and progesterone receptor positive (ER+/PR+) MCF-7 and triple negative MDA-MB-231 breast cancer cell lines is examined and these compounds can provide a starting point for the development of novel drug molecules against triple negative breast cancers.
Journal ArticleDOI
PAR-4 as a possible new target for pancreatic cancer therapy
TL;DR: This review provides comprehensive knowledge of the significance of Par-4 and its association with kras status in PC, along with the crosstalk with crucial resistance and survival molecules NF-κB and Bcl-2 that ultimately are responsible for the overall poor outcome of different therapeutic approaches in this disease.
Patent
Antibodies to a novel EGF-receptor related protein (ERRP)
TL;DR: In this article, the authors used ERRP (EGF-Receptor Related Protein) specific antibodies that could be used to study the functional properties of ERRP and as a diagnostic and prognostic tool for malignancies.